Literature DB >> 6393866

Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum.

T F McCutchan, J A Welsh, J B Dame, I A Quakyi, P M Graves, J C Drake, C J Allegra.   

Abstract

Clones of Plasmodium falciparum prepared from recent isolates of infected blood were studied to determine the molecular mechanism of naturally occurring pyrimethamine resistance. Total DNA, as well as thymidylate synthetase and dihydrofolate reductase activities, were characterized from these lines. Restriction analysis of DNA from pyrimethamine-susceptible and -resistant lines of the parasite showed no obvious amplification of any DNA fragment. Further, analysis of DNA from resistant and susceptible lines by centrifugation in cesium chloride-ethidium bromide revealed no extrachromosomal amplification in the resistant line. Comparison of the dihydrofolate reductase enzyme activity in the two lines revealed similar KmS for substrate but a large difference in the inhibition constant for pyrimethamine. Additionally, the enzyme from the resistant line was considerably more stable in vitro than the corresponding enzyme from the susceptible line. The thymidylate synthetase activity in the two lines was similar and unaffected by pyrimethamine. The mechanism of drug resistance in this isolate involves altered properties of the dihydrofolate reductase conferring both a different affinity for the drug and increased stability.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6393866      PMCID: PMC179988          DOI: 10.1128/AAC.26.5.656

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  TECHNIQUES FOR STUDY OF RESISTANCE TO FOLIC ACID ANTAGONISTS.

Authors:  J R BERTINO; G A FISCHER
Journal:  Methods Med Res       Date:  1964

2.  Enzyme variation in Plasmodium falciparum in the Gambia.

Authors:  R Carter; I A McGregor
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

3.  Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.

Authors:  R Ferone; J J Burchall; G H Hitchings
Journal:  Mol Pharmacol       Date:  1969-01       Impact factor: 4.436

4.  Drug sensitivity and isoenzyme type in cloned lines of Plasmodium falciparum.

Authors:  P M Graves; R Carter; J S Keystone; D C Seeley
Journal:  Am J Trop Med Hyg       Date:  1984-03       Impact factor: 2.345

5.  Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate.

Authors:  T R Burkot; J L Williams; I Schneider
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

6.  Vestibulospinal reflexes as a function of microgravity.

Authors:  M F Reschke; D J Anderson; J L Homick
Journal:  Science       Date:  1984-07-13       Impact factor: 47.728

7.  An isotopic assay for thymidylate synthetase.

Authors:  D Roberts
Journal:  Biochemistry       Date:  1966-11       Impact factor: 3.162

8.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

9.  Comparative studies on dihydrofolate reductases from Plasmodium falciparum and Aotus trivirgatus.

Authors:  S C Kan; W A Siddiqui
Journal:  J Protozool       Date:  1979-11

10.  Cloning and characterization of a ribosomal RNA gene from Plasmodium berghei.

Authors:  J B Dame; T F McCutchan
Journal:  Mol Biochem Parasitol       Date:  1983-07       Impact factor: 1.759

View more
  12 in total

1.  Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene.

Authors:  D J Bzik; W B Li; T Horii; J Inselburg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Antifolate drug selection results in duplication and rearrangement of chromosome 7 in Plasmodium chabaudi.

Authors:  A F Cowman; A M Lew
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

3.  Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.

Authors:  D S Peterson; D Walliker; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum.

Authors:  A F Cowman; M J Morry; B A Biggs; G A Cross; S J Foote
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.

Authors:  S J Foote; D Galatis; A F Cowman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 6.  Modern malaria chemoprophylaxis.

Authors:  G Dennis Shanks; Michael D Edstein
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase.

Authors:  P K Rathod; S Reshmi
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

8.  Pyrimethamin-resistant Plasmodium falciparum lack cross-resistance to methotrexate and 2,4-diamino-5-(substituted benzyl) pyrimidines.

Authors:  R D Walter; B Bergmann; M Kansy; M Wiese; J K Seydel
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

9.  Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate.

Authors:  C J Allegra; J A Kovacs; J C Drake; J C Swan; B A Chabner; H Masur
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

10.  Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax.

Authors:  Mallika Imwong; Bruce Russell; Rossarin Suwanarusk; Alexis Nzila; Mara L Leimanis; Kanlaya Sriprawat; Supaporn Kaewpongsri; Aung Pyae Phyo; Georges Snounou; Francois Nosten; Laurent Renia
Journal:  J Infect Dis       Date:  2010-12-09       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.